NVIDIA (NVDA) Looks to Accelerate Drug Discovery and Life Sciences R&D with BioNeMo AI Platform Expansion

NVIDIA Corporation (NASDAQ:NVDA) is included in our list of the best stocks to buy right now.

NVIDIA (NVDA) Looks to Accelerate Drug Discovery and Life Sciences R&D with BioNeMo AI Platform Expansion

On January 12, 2026, NVIDIA Corporation (NASDAQ:NVDA) announced a major expansion of its BioNeMo platform at the J.P. Morgan Healthcare Conference. The platform, designed to accelerate AI-driven biology and drug discovery, integrates high-throughput data processing, model training, and deployment. With this, BioNeMo helps life sciences companies convert vast experimental datasets into actionable insights.

The platform now boasts new capabilities such as Clara RNAPro for RNA structure prediction, ReaSyn v2 for practical AI-designed drug synthesis, and nvMolKit, a GPU-accelerated cheminformatics tool. The outcomes of these tools enable continuous learning cycles while reducing R&D costs in an industry that currently spends roughly $300 billion annually.

On the same day, Reuters reported that NVIDIA Corporation (NASDAQ:NVDA) and Eli Lilly announced a $1 billion joint research lab in the San Francisco Bay Area over five years. By leveraging Nvidia’s next-generation Vera Rubin AI chips, the lab will allow researchers from both firms to collaborate to generate new data to train biotech AI models, accelerating drug discovery. This move follows Lilly’s previous investment in a supercomputer using Nvidia Grace Blackwell chips.

NVIDIA Corporation (NASDAQ:NVDA) focuses on designing GPUs, AI accelerators, and computing platforms, and on providing hardware and software solutions for the gaming, enterprise, AI, robotics, and biotechnology markets.

While we acknowledge the potential of NVDA to grow, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an AI stock that is more promising than NVDA and that has 100x upside potential, check out our report about this cheapest AI stock.

READ NEXT: 7 Best Rising Tech Stocks to Buy Now and 12 Best Multibagger Stocks to Buy Heading into 2026.

Disclosure: None.